(Q34316525)

1 August 2017

Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome (English)

1 reference

1 August 2017

1 reference

Shibuya K

1

1 reference

1 August 2017

Coulson WF

2

1 reference

1 August 2017

Wollman JS

3

1 reference

1 August 2017

Wakayama M

4

1 reference

1 August 2017

Ando T

5

1 reference

1 August 2017

Oharaseki T

6

1 reference

1 August 2017

Takahashi K

7

1 reference

1 August 2017

Naoe S

8

1 reference

1 August 2017

1 January 2001

1 reference

International Journal of Infectious Diseases

1 August 2017

1 reference

1 August 2017

5

1 reference

1 August 2017

2

1 reference

1 August 2017

78-85

1 reference

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcal infections in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Overview: cryptococcosis in the patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Pulmonary cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Th1 and Th2 cytokines in mice with invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

The spectrum of pulmonary cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

What makes Cryptococcus neoformans a pathogen?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Therapy for cryptococcal meningitis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Massive Pulmonary Cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Primary Complex of Cryptococcus and Pulmonary Lymph Nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcosis: Current status

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi?

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophages: effects of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2801%2990030-X

7 January 2021

10.1016/S1201-9712(01)90030-X

Identifiers

DOI

1 reference

1 August 2017

1 reference